[Pharmacological and clinical profile of rosuvastatin calcium (Crestor)].
Ohfuji
Kazumi
K
Kazumi.Ohfuji@astrazeneca.com
Yano
Seiichi
S
Yamaguchi
Motonori
M
Smith
Graham
G
Hirata
Masako
M
Shimada
Hitoshi
H
Izuishi
Koji
K
Shinagawa
Jotaro
J
Matsunaga
Kazuki
K
D000818:Animals; D002784:Cholesterol / Q000097:blood; D005464:Fluorobenzenes / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy; D011743:Pyrimidines / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D051381:Rats; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*
D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D002784:Cholesterol